Stocks & Investing
Fri, October 4, 2024
[ 12:00 AM ] - WOPRAI
Thu, September 26, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, September 19, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, September 13, 2024
[ 12:00 AM ] - WOPRAI
Fri, September 6, 2024
[ 12:00 AM ] - WOPRAI
Wed, August 28, 2024
[ 12:00 AM ] - WOPRAI
Fri, August 16, 2024
[ 12:00 AM ] - WOPRAI
Thu, August 15, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, August 14, 2024
[ 12:00 AM ] - WOPRAI
Tue, August 13, 2024
[ 12:00 AM ] - WOPRAI
Fri, August 9, 2024
[ 12:00 AM ] - WOPRAI
Wed, August 7, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, August 6, 2024
[ 12:00 AM ] - WOPRAI
Fri, August 2, 2024
[ 12:00 AM ] - WOPRAI
Tue, June 25, 2024
[ 12:00 AM ] - WOPRAI
Fri, June 14, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, June 4, 2024
[ 12:00 AM ] - WOPRAI
Tue, May 28, 2024
[ 12:00 AM ] - WOPRAI
Tue, May 14, 2024
[ 12:00 AM ] - WOPRAI
Fri, May 3, 2024
[ 12:00 AM ] - WOPRAI
Wed, April 3, 2024
[ 12:00 AM ] - WOPRAI
Fri, March 15, 2024
[ 12:00 AM ] - WOPRAI
Thu, March 14, 2024 Gregory Renza Maintained (VRCA) at Buy with Decreased Target to $11 on, Oct 4th, 2024
Gregory Renza of RBC Capital, Maintained "Verrica Pharmaceuticals Inc." (VRCA) at Buy with Decreased Target from $13 to $11 on, Oct 4th, 2024.
Gregory has made no other calls on VRCA in the last 4 months.
There are 2 other peers that have a rating on VRCA. Out of the 2 peers that are also analyzing VRCA, all agree with Gregory's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Serge Belanger of "Needham" Downgraded from Strong Buy to Hold and Held Target at $12 on, Thursday, October 3rd, 2024
- Kemp Dolliver of "Brookline Capital" Downgraded from Strong Buy to Hold on, Wednesday, October 2nd, 2024
